MRI for clinically suspected prostate cancer —the disparity between private and public sectors
ConclusionsPre-biopsy mpMRI for clinically suspected prostate cancer is emerging as a standard of practice in Ireland. International guidelines are also changing to reflect latest clinical trial evidence. Private health insurance providers should amend their policies to reflect current clinical practices already adopted in the public sector.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Health Insurance | Health Management | Insurance | Ireland Health | MRI Scan | PET Scan | Prostate Cancer | Science | Ultrasound